4//SEC Filing
Auwaerter Paul Gisbert 4
Accession 0001415889-24-000656
CIK 0001133869other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:15 PM ET
Size
10.8 KB
Accession
0001415889-24-000656
Insider Transaction Report
Form 4
Auwaerter Paul Gisbert
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+29,250→ 29,250 totalExercise: $5.12Exp: 2034-01-02→ Common Stock (29,250 underlying) - Award
Stock Option (Right to Buy)
2024-01-02+890→ 890 totalExercise: $5.12Exp: 2034-01-02→ Common Stock (890 underlying) - Award
Stock Option (Right to Buy)
2024-01-02+6,760→ 6,760 totalExercise: $5.12Exp: 2034-01-02→ Common Stock (6,760 underlying)
Footnotes (3)
- [F1]The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
- [F2]The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service.
- [F3]The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001982730
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:15 PM ET
- Size
- 10.8 KB